Before the identification of CD117 expression in GISTs, CD34 was considered the best marker for GIST, but it was neither sensitive (only for two-thirds of GISTs) nor specific (immunoreactive in fibroblastic and endothelial cell tumors) [20]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.